Published in J Urol on June 01, 2004
Contemporary inguinal lymph node dissection: minimizing complications. World J Urol (2008) 1.00
Penile cancer: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2013) 0.97
Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer. World J Urol (2008) 0.95
Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma. BJU Int (2013) 0.92
Metastatic penile carcinoma - an update on the current diagnosis and treatment options. Cent European J Urol (2014) 0.89
What next? Managing lymph nodes in men with penile cancer. Can Urol Assoc J (2008) 0.84
Lymphoscintigraphy in penile cancer: limited value of sentinel node biopsy in patients with clinically suspicious lymph nodes. World J Urol (2006) 0.83
New concept for the prevention and treatment of metastatic lymph nodes using chemotherapy administered via the lymphatic network. Sci Rep (2016) 0.78
Reliability of radioisotope-guided sentinel lymph node biopsy in penile cancer: verification in consideration of the European guidelines. BMC Urol (2015) 0.76
A study on the value of computer-assisted assessment for SPECT/CT-scans in sentinel lymph node diagnostics of penile cancer as well as clinical reliability and morbidity of this procedure. Cancer Imaging (2016) 0.75
Feasibility of performing dynamic sentinel lymph node biopsy as a delayed procedure in penile cancer. World J Urol (2015) 0.75
Radioguided surgery in urological malignancies. Indian J Urol (2008) 0.75
Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies? Clin Transl Imaging (2016) 0.75
Real-time sentinel lymph node biopsy guidance using combined ultrasound, photoacoustic, fluorescence imaging: in vivo proof-of-principle and validation with nodal obstruction. Sci Rep (2017) 0.75
Re: reproducibility of lymphoscintigraphy for lymphatic mapping in patients with penile carcinoma. J Urol (2006) 0.75
Re: How to avoid false-negative dynamic sentinel node procedures in penile carcinoma. J Urol (2005) 0.75
Sentinel lymph node biopsy in renal malignancy: The past, present and future. World J Nephrol (2016) 0.75
Value and efficiency of sentinel lymph node diagnostics in patients with penile carcinoma with palpable inguinal lymph nodes as a new multimodal, minimally invasive approach. Eur J Nucl Med Mol Imaging (2016) 0.75
More precise prediction in Chinese patients with penile squamous cell carcinoma: protein kinase CK2α catalytic subunit (CK2α) as a poor prognosticator. Oncotarget (2017) 0.75
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56
Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol (2005) 2.31
Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl (2000) 2.23
Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14
[Guideline 'Melanoma' (3rd revision)]. Ned Tijdschr Geneeskd (2005) 2.08
Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide. Eur J Nucl Med (1994) 2.05
Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg (2001) 1.79
The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer. Ann Oncol (2011) 1.73
Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg (2000) 1.71
Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature. Eur J Surg Oncol (2008) 1.69
Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence. J Urol (2006) 1.67
Critical appraisal of the PADUA classification and assessment of the R.E.N.A.L. nephrometry score in patients undergoing partial nephrectomy. J Urol (2011) 1.64
Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury. Radiother Oncol (1995) 1.57
Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol (1999) 1.55
Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs. J Am Coll Surg (1996) 1.54
Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients. J Surg Oncol (2005) 1.52
High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma. Br J Surg (2004) 1.46
Safety and efficacy of isolated limb perfusion in elderly melanoma patients. Ann Surg Oncol (2002) 1.46
Clinical outcomes after sexuality preserving cystectomy and neobladder (prostate sparing cystectomy) in 44 patients. J Urol (2008) 1.45
Sequential treatment for recurrent localized prostate cancer. J Surg Oncol (2008) 1.45
Excision biopsy of breast lesions changes the pattern of lymphatic drainage. Br J Surg (2007) 1.43
[Incidence and treatment of prostatic carcinoma in the region of the Comprehensive Cancer Center Amsterdam, 1989-1994]. Ned Tijdschr Geneeskd (1996) 1.40
[Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer]. Ned Tijdschr Geneeskd (2004) 1.40
Finding lymph node metastases in invasive breast cancer: sampling or sentinel node procedure? Eur J Surg Oncol (2002) 1.39
[Internal radiotherapy in prostatic carcinoma; disappointing long-term results of retropubic Iodine-125 implantation]. Ned Tijdschr Geneeskd (1996) 1.38
[Less mutilating treatment of penile carcinoma]. Ned Tijdschr Geneeskd (2005) 1.35
Lymphoscintigraphy and SPECT/CT in multicentric and multifocal breast cancer: does each tumour have a separate drainage pattern? Results of a Dutch multicentre study (MULTISENT). Eur J Nucl Med Mol Imaging (2012) 1.29
Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification. J Nucl Med (2000) 1.25
Upper urinary tract cancer: location is correlated with prognosis. Eur Urol (2005) 1.24
A trial of consent procedures for future research with clinically derived biological samples. Br J Cancer (2009) 1.22
Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis. Eur Urol (1999) 1.22
Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol (2001) 1.19
EAU Guidelines on Penile Cancer. Eur Urol (2004) 1.19
Detection of unknown occult primary tumors using positron emission tomography. Cancer (1998) 1.18
Clinical outcomes after sexuality preserving cystectomy and neobladder (prostate sparing cystectomy) in 44 patients. J Urol (2005) 1.18
Sarcomatoid squamous cell carcinoma of the penis: a clinical and pathological study of 5 cases. J Urol (2004) 1.16
Morbidity of dynamic sentinel node biopsy in penile carcinoma. J Urol (2005) 1.15
Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol (1997) 1.13
Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg (2000) 1.13
Symptomatic brain metastases from small-cell carcinoma of the urinary bladder: The Netherlands Cancer Institute experience and literature review. Ann Oncol (2010) 1.12
Phase II study of intermittent continuous infusion of low-dose recombinant interleukin-2 in advanced melanoma and renal cell cancer. Ann Oncol (1994) 1.10
The hidden sentinel node in breast cancer. Eur J Nucl Med Mol Imaging (2002) 1.10
[The course of prostatic carcinoma]. Ned Tijdschr Geneeskd (1995) 1.07
[Iodine-125 implantation in localized cancer of the prostate; too early for rejoicing]. Ned Tijdschr Geneeskd (1998) 1.07
First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma. Eur J Cancer (1995) 1.05
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy. Eur J Nucl Med Mol Imaging (2012) 1.05
History of sentinel node and validation of the technique. Breast Cancer Res (2001) 1.05
Single intralesional tracer dose for radio-guided excision of clinically occult breast cancer and sentinel node. Ann Surg Oncol (2001) 1.04
Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease. Nucl Med Commun (2002) 1.04
The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques. Eur J Surg Oncol (2009) 1.03
Epidemiology of human papillomavirus infection. Scand J Urol Nephrol Suppl (2000) 1.01
Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer (1998) 1.01
EAU guidelines on penile cancer. Eur Urol (2002) 0.99
The role of initial immunotherapy as selection for nephrectomy in patients with metastatic renal cell carcinoma and the primary tumor in situ. Eur Urol (2002) 0.99
Intraoperative radioguidance with a portable gamma camera: a novel technique for laparoscopic sentinel node localisation in urological malignancies. Eur J Nucl Med Mol Imaging (2009) 0.98
Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol (2000) 0.98
The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusion. Eur J Surg Oncol (2007) 0.98
Vascular complications of isolated limb perfusion. Eur J Surg Oncol (1998) 0.97
Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med (1999) 0.97
Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours. Eur J Cancer (1996) 0.97
Reliability of lymphoscintigraphy in indicating the number of sentinel nodes in melanoma patients. Ann Surg Oncol (2000) 0.96
Sentinel node biopsy for melanoma in the head and neck region. Head Neck (2000) 0.96
Multimodal surgical guidance towards the sentinel node in vulvar cancer. Gynecol Oncol (2013) 0.96
Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br J Cancer (2003) 0.95
Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors. Ann Oncol (2012) 0.94
A new method to determine dose-effect relations for local lung-function changes using correlated SPECT and CT data. Radiother Oncol (1993) 0.94
Lymphatic mapping and sentinel node biopsy in Merkel's cell carcinoma. Eur J Surg Oncol (2006) 0.94
The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma. Br J Cancer (1998) 0.94
The illusion of the learning phase for lymphatic mapping. Ann Surg Oncol (2002) 0.93
Diagnosis and clinical presentation of premalignant lesions of the penis. Scand J Urol Nephrol Suppl (2000) 0.93
Sentinel nodes outside lymph node basins in patients with melanoma. Br J Surg (2001) 0.93
Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control. Int J Radiat Oncol Biol Phys (1998) 0.93
Severe acute regional toxicity after normothermic or 'mild' hyperthermic isolated limb perfusion with melphalan for melanoma. Melanoma Res (1995) 0.93
Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma. Br J Cancer (2003) 0.92
Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy. Br J Surg (2007) 0.92
Laser therapy for carcinoma in situ of the penis. J Urol (2001) 0.92
Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors. J Nucl Med (1998) 0.92
Eight false negative sentinel node procedures in breast cancer: what went wrong? Eur J Surg Oncol (2003) 0.91
Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience. Eur Urol (2005) 0.91
Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma. J Am Coll Surg (1999) 0.90
Thirty-five years of isolated limb perfusion for melanoma: indications and results. Br J Surg (1996) 0.90